首页> 外国专利> Methods for reducing the uterotrophic effect of tamoxifen and tamoxifen analogs

Methods for reducing the uterotrophic effect of tamoxifen and tamoxifen analogs

机译:降低他莫昔芬和他莫昔芬类似物的子宫营养作用的方法

摘要

The present invention provides a method of minimizing the uterotrophic effect of non-steroidal antiestrogen compounds of formula II CHEM wherein either R4 is H or a lower alkyl radical and R5 is a lower alkyl radical, or R4 and R5 are joined together with the adjacent nitrogen atom to form a heterocyclic radical; R6 is H or a lower alkyl radical; R7 is H, halo, OH, a lower alkyl radical, or is a buta-1,3-dienyl radical which together with the adjacent benzene ring forms a naphthyl radical; R8 is H or OH; and n is 2; or a pharmaceutically acceptable salt thereof, wherein said formula II compound is administered to a woman for the treatment or prevention of breast carcinoma, comprising concurrently or sequentially administering to said woman a compound of formula I CHEM wherein R1 is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C4-C6 alkyl); R2 is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C4-C6 alkyl); n is 2 or 3; and R3 is 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidinyl, 4-morpholino, dimethylamino, diethylamino, or 1-hexamethyleneimino; or a pharmaceutically acceptable salt thereof. The present invention further provides pharmaceutical compositions comprising a compound of formula I and a compound of formula II together with a pharmaceutically acceptable carrier, excipient, or diluent.
机译:本发明提供了一种使式II 的非甾体抗雌激素化合物的子宫营养作用最小化的方法,其中R 4是H或低级烷基,R 5是低级烷基,或R < 4和R 5与相邻的氮原子连接在一起形成杂环基。 R 6为H或低级烷基。 R 7为H,卤素,OH,低级烷基或为与相邻的苯环一起形成萘基的丁基-1,3-二烯基。 R 8为H或OH; n是2;或其式药学上可接受的盐,其中将所述式II化合物施用于妇女以治疗或预防乳腺癌,包括向所述妇女同时或依次施用式I 的化合物,其中R 1为-H ,-OH,-O(C 1 -C 4烷基),-OCOC 6 H 5,-OCO(C 1 -C 6烷基)或-OSO 2(C 4 -C 6烷基); R 2为-H,-OH,-O(C 1 -C 4烷基),-OCOC 6 H 5,-OCO(C 1 -C 6烷基)或-OSO 2(C 4 -C 6烷基); n为2或3; R 3为1-哌啶基,1-吡咯烷基,甲基-1-吡咯烷基,二甲基-1-吡咯烷基,4-吗啉代,二甲基氨基,二乙基氨基或1-六亚甲基亚氨基。或其药学上可接受的盐。本发明进一步提供了药物组合物,其包含式I的化合物和式II的化合物以及药学上可接受的载体,赋形剂或稀释剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号